General Infectious Diseases Maintenance of Certification 2018
The IDSA General Infectious Diseases MOC Module 2018 is a tool for self-evaluation of medical knowledge in General Infectious Diseases medicine. The module consists of 45 multiple-choice questions; the majority contains case information and all include educational links and answer rationales. American Board of Internal Medicine (ABIM) diplomates who successfully complete this activity are eligible to receive 15 points toward the self-evaluation of medical knowledge requirement. Participants may also earn a maximum of 15.0 AMA PRA Category 1 Credit(s). ™
This CME activity is intended for infectious diseases physicians, ID academicians, and internal medicine physicians.
At the conclusion of this activity, participants will be able to:
- Identify gaps in infectious diseases medical knowledge where further study is needed for board preparation and patient management
- Improve competence in the area of infectious diseases medicine regarding diagnosis, treatments, and other aspects of patient management
- Evaluate and revise patient management strategies
- Improve clinical decision-making skills in infectious diseases medicine
Faculty and Disclosures
Bradley Allen, MD, PhD, Indiana University School of Medicine, Associate Professor of Clinical Medicine and Infectious Diseases; Associate Dean for Medical Student Education. Nothing to disclose
Irmgard Behlau, MD, Tufts University School of Medicine. Nothing to disclose
Lyssette Cardona, MD, Cleveland Clinic, Division Chief, Caregiver Wellbeing, Infectious Diseases and Occupational Health, Nothing to disclose
Natasha Chida, MD, Johns Hopkins University School of Medicine. Assistant Professor. Nothing to disclose
Edward Dominguez, MD, Methodist Hospital, Medical Director, Organ Transplant ID; Tetraphase: Advisory, consultant role; Theravance, Amgen, Merck: Advisory, consultant/honoraria
Aaron Glatt, MD; South Nassau Community Hospital, Chair, Department of Medicine. Nothing to disclose
Noreen Hynes, MD, MPH, Panel Chair, Associate Professor of Medicine, The Johns Hopkins University; Nothing to disclose
Mary Anne Jackson, MD, Division Director, Infectious Diseases, Children’s Mercy Hospital. Nothing to disclose
Kenneth Kaye, MD, Brigham and Women’s Hospital, Staff Physician; American Medical Seminars, Speaker; Abbott Labs, Allergan, Glaxo SmithKline, Merck: stocks/bonds
Vicki Morrison, MD, Staff Physician, Hennepin County Medical Center. GlaxoSmithKline, Merck, Takeda: Advisory/Consultant role; Gilead, Celgene, Genentech, Pharmacyclics: Speaker’s Bureau
Christopher Ohl, MD, Professor of Medicine, Wake Forest School of Medicine. Nothing to disclose
Kathleen Matikonis, MA, IDSA Senior Education Officer. Nothing to disclose
Rachel Shnekendorf, MPH, IDSA Director of Education. Nothing to disclose
All relevant financial relationships have been mitigated.
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.
- 15.00 ABIM MOC II
- 15.00 AMA PRA Category 1 Credit(s)™